CA2828072A1 - Indirect substrates for microorganisms metabolizing 1,2-propanediol - Google Patents

Indirect substrates for microorganisms metabolizing 1,2-propanediol Download PDF

Info

Publication number
CA2828072A1
CA2828072A1 CA2828072A CA2828072A CA2828072A1 CA 2828072 A1 CA2828072 A1 CA 2828072A1 CA 2828072 A CA2828072 A CA 2828072A CA 2828072 A CA2828072 A CA 2828072A CA 2828072 A1 CA2828072 A1 CA 2828072A1
Authority
CA
Canada
Prior art keywords
rhamnose
pectin
fucose
reuteri
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2828072A
Other languages
English (en)
French (fr)
Inventor
Stefan Roos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogaia AB
Original Assignee
Biogaia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/400,735 external-priority patent/US20120263696A1/en
Application filed by Biogaia AB filed Critical Biogaia AB
Publication of CA2828072A1 publication Critical patent/CA2828072A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/22—Processes using, or culture media containing, cellulose or hydrolysates thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/231—Pectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2828072A 2011-02-23 2012-02-23 Indirect substrates for microorganisms metabolizing 1,2-propanediol Abandoned CA2828072A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201161463846P 2011-02-23 2011-02-23
US61/463,846 2011-02-23
US201161517130P 2011-04-14 2011-04-14
US61/517,130 2011-04-14
US13/400,735 2012-02-21
US13/400,735 US20120263696A1 (en) 2011-04-14 2012-02-21 Indirect Substrates for Microorganisms Metabolizing 1,2-Propanediol
PCT/SE2012/050202 WO2012115588A1 (en) 2011-02-23 2012-02-23 Indirect substrates for microorganisms metabolizing 1,2-propanediol

Publications (1)

Publication Number Publication Date
CA2828072A1 true CA2828072A1 (en) 2012-08-30

Family

ID=48782680

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2828072A Abandoned CA2828072A1 (en) 2011-02-23 2012-02-23 Indirect substrates for microorganisms metabolizing 1,2-propanediol

Country Status (12)

Country Link
EP (1) EP2677886A4 (de)
JP (1) JP2014513058A (de)
KR (1) KR20130140812A (de)
CN (1) CN103402377A (de)
AU (1) AU2012221154B2 (de)
BR (1) BR112013020695A2 (de)
CA (1) CA2828072A1 (de)
MX (1) MX2013009650A (de)
RU (1) RU2013142920A (de)
SG (1) SG191355A1 (de)
WO (1) WO2012115588A1 (de)
ZA (1) ZA201304704B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220211732A1 (en) * 2019-05-23 2022-07-07 Evonik Operations Gmbh Prebiotic compositions
EP4056052A1 (de) * 2021-03-12 2022-09-14 Biogaia AB Gos-vorkonditionierung von l. reuteri und gos in endformulierung
EP4056053A1 (de) * 2021-03-12 2022-09-14 Biogaia AB Vorbehandlung von l. reuteri

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3587219B2 (ja) * 1995-04-20 2004-11-10 アサマ化成株式会社 食品用保存剤
GB2320883A (en) * 1996-01-05 1998-07-08 Hyprotech Treatment of soya beans
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EP1446023B1 (de) * 2001-11-12 2009-02-25 Mars, Incorporated Nahrungsmittel für katzen und hunde
AU2003250503A1 (en) * 2002-06-13 2003-12-31 University College Cork - National University Of Ireland, Cork Probiotic therapies using lactobacillus reuteri
FR2844453B1 (fr) * 2002-09-13 2006-05-19 Agronomique Inst Nat Rech Utilisation de pre-biotiques pour la prevention de l'installation du diabete de type ii
DE602006017423D1 (de) * 2005-11-14 2010-11-18 Unilever Nv Essbares produkt, das ginseng-polysaccharide und gesunde bakterien enthält
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
EP2143341A1 (de) * 2008-07-08 2010-01-13 Nestec S.A. Nährstoffzusammensetzung mit Oligosaccharid-Mischung
US8617537B2 (en) * 2008-06-10 2013-12-31 Biogaia Ab Controlled activation of the reuterin-production machinery of lactobacillus
CN102202527B (zh) * 2008-11-03 2014-12-31 雀巢产品技术援助有限公司 包含益生菌并改善睡眠模式的营养组合物
ATE489856T1 (de) * 2009-01-06 2010-12-15 Rosebud Ag Symbiotische zusammensetzung und ihr herstellungsverfahren
AU2010281534B2 (en) * 2009-07-27 2014-10-16 Société des Produits Nestlé S.A. Nutritional compositions comprising fiber and probiotics
CN101671399B (zh) * 2009-10-10 2011-05-11 山东大学威海分校 一种高纯度高硫酸根岩藻聚糖硫酸酯的制备方法

Also Published As

Publication number Publication date
SG191355A1 (en) 2013-08-30
BR112013020695A2 (pt) 2016-10-25
WO2012115588A1 (en) 2012-08-30
NZ613318A (en) 2015-10-30
JP2014513058A (ja) 2014-05-29
CN103402377A (zh) 2013-11-20
AU2012221154B2 (en) 2015-12-10
RU2013142920A (ru) 2015-03-27
KR20130140812A (ko) 2013-12-24
EP2677886A4 (de) 2015-09-02
EP2677886A1 (de) 2014-01-01
ZA201304704B (en) 2014-09-25
AU2012221154A1 (en) 2013-07-18
MX2013009650A (es) 2013-09-26

Similar Documents

Publication Publication Date Title
EP1613180B1 (de) Symbiotische zusammensetzung
EP3345606A1 (de) Verfahren und zusammensetzungen zum anregen von nützlichen bakterien im verdauungstrakt
CN1312285C (zh) 制造1,4－二羟基－2萘甲酸的方法
AU2008251346A1 (en) Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
EP2173196A1 (de) Verwendung von probiotika und ballaststoffen bei diarrhö
WO2015146916A1 (ja) 新規ラクトバチラス・パラカゼイ株
CN115944665A (zh) 一种改善肠道菌群平衡的益生菌剂及其制备方法和应用
US20120263696A1 (en) Indirect Substrates for Microorganisms Metabolizing 1,2-Propanediol
US20140065696A1 (en) Immunomodulatory Properties of Lactobacillus Strains
CN112237287B (zh) 一株能够缓解便秘的鼠李糖乳杆菌lr519及其组合物
Staka et al. Impact of oat-based products on human gastrointestinal tract
AU2012221154B2 (en) Indirect substrates for microorganisms metabolizing 1,2-propanediol
KR20040037011A (ko) 유산균 함유 식품조성물 및 그 제조방법
EP4151222A1 (de) Zusammensetzung zur optimierung der urolithinproduktion in einem menschen
KR20160113867A (ko) 변비 개선용 조성물 및 이로 제조된 건강식품
NZ613318B2 (en) Indirect substrates for microorganisms metabolizing 1,2-propanediol
CN121337026B (zh) 一种透明质酸钠修饰脂质体包埋低聚果糖益生元及其制备方法和应用
HK1191516A (en) Indirect substrates for microorganisms metabolizing 1,2-propanediol
KR102687185B1 (ko) 폴리갈락트론산을 포함하는 장내 균총 개선용 조성물
HK1186490B (en) Improvement of immunomodulatory properties of lactobacillus strains
HK1148193A (en) Medium chain dicarboxylic acids, their derivates and metabolic disorders

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20180223